| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY | 2021-03-31 FY |
|---|---|---|---|---|---|---|
| Revenue | – | – | – | – | $82.74M | $20.82M |
| Cost of Revenue | – | – | – | – | – | – |
| Gross Profit | – | – | – | – | – | – |
| Operating Expenses | $68.01M | $58.67M | $57.34M | $54.83M | $51.23M | – |
| R&D | – | – | – | – | – | – |
| SG&A | $16.27M | $15.39M | $15.82M | $15.26M | $14.31M | – |
| Operating Income | $47.91M | $49.90M | $50.31M | $54.15M | $56.97M | – |
| Interest Expense | – | – | $18.78M | $17.57M | $17.94M | – |
| Tax Expense | – | – | – | – | – | – |
| Net Income | $25.47M | $30.42M | $29.61M | $42.18M | $38.86M | $2.96M |
| EPS (basic) | 1.1600 | 1.4100 | 1.3800 | 2.0000 | 1.8700 | 0.1300 |
| EPS (diluted) | 1.1500 | 1.4000 | 1.3800 | 1.9900 | 1.8500 | 0.1300 |
| Shares (diluted) | $20.91M | $20.72M | $20.56M | $20.45M | $20.26M | $20.06M |